Catalog  |  Cart  |  Log In

 

STR Data Goes To Court - A Laboratory Perspective

 

Charlotte J. Word, Ph.D.
Cellmark Diagnostics, 20271 Goldenrod Lane, Germantown, MD 20876

× Ø × Ø × Ø × Ø × Ø × Ø × Ø × Ø × Ø × Ø × Ø × Ø × Ø × Ø × Ø

ABSTRACT

Over the past ten years, the United States and other countries have seen the introduction of human DNA identification tests on various biological samples in crime laboratories, which has been followed by presentation of the test results and conclusions to judges and juries in courts of law. Extensive experience has been accumulated regarding the issues that affect the admissibility and presentation of "new and novel" test results in court. The newest form of DNA testing to become commercially available for forensic DNA analysis is STR (short tandem repeat) testing. Cellmark Diagnostics has been using the CTT GenePrintÔ STR Multiplex System for almost three years in forensic casework and the GenePrintÔ Sex Determination System (Amelogenin) in conjunction with CTT for over a year. This presentation will focus on the use of STR testing in several forensic cases done at Cellmark Diagnostics that have gone to court and will specifically address the advantages of using STR testing in these cases and the approaches used to present the data in court.

INTRODUCTION

Cellmark Diagnostics first started doing polymerase chain reaction (PCR) testing with STRs in 1991 when casualties of Desert Storm were typed under a contract with the United States Department of the Army. These studies were performed using systems from the laboratory of Dr. Thomas Caskey. Casework analysis using the CSF1P0, TPOX, and TH01 (CTT) GenePrintÔ STR System from Promega began in the fall of 1994, and amelogenin was added to the CTT system (CTT-A) in the spring of 1996. Since 1994, Cellmark Diagnostics has performed STR testing in over 250 cases and has testified to the results in over 30 cases.

Since 1987, many laboratories in the United States doing forensic DNA identification testing have acquired vast experience in performing DNA tests and taking the results and conclusions from those tests into the courtroom for presentation to judges and juries. Restriction fragment length polymorphism (RFLP) data have been presented in numerous courts and there are a significant number of state appellate rulings accepting RFLP data. Similarly, the results from PCR testing have also been widely presented in courts in the United States resulting in many appellate rulings accepting PCR testing. Currently, most of the appellate rulings regarding PCR testing reference data obtained using the AmpliTypeÔ DQa PCR Forensic DNA Amplification and Typing Kit (Perkin-Elmer), however, there have been several more recent rulings accepting PM and D1S80 data. As scientists, we can rely on our past experience when testifying to scientific data produced using the commercially "newer" STR systems.

DISCUSSION

Our role as scientific expert witnesses in the courtroom is to educate the jury and/or judge regarding the type of testing that has been done, the results and conclusions of the tests, and the limitations of the tests. It may be helpful to explain the genetic basis for each type of test and the advantages and disadvantages of the test systems (e.g., PCR testing has the benefit over RFLP testing of being able to provide results from very small biological samples that are unsuitable for RFLP testing). There are two major types of variations in nuclear DNA used for human identification testing. One type of variation is a single-base change occurring at a specific location in the DNA (e.g., one person has an "A" and another person has a "G" at that location). These variations are commonly analyzed in forensic DNA laboratories using oligonucleotide probes specific for the sequence variation in amplified PCR products, such as in the dot blot analysis used in the AmpliTypeÔ DQa, PM and PM + DQA1 test kits. The second type of variation results from a difference in the number of blocks of tandemly repeated sequences found at a specific location in the DNA which results in DNA length variations. These variations are commonly analyzed using electrophoresis of the DNA through a gel and observing differences in migration distances of the different length DNA fragments. Blocks of large repeated DNA sequences are referred to as variable number tandem repeats (VNTR) and are analyzed using RFLP testing. Variable numbers of blocks of shorter repeated DNA sequences that are amplified using the PCR are commonly referred to as amplified fragment length polymorphisms (AmpFLPs; e.g., D1S80). Short tandem repeats (STRs) refer to tandemly-repeated blocks of very short sequences (generally two, three or four bases) and like AmpFLPs, are analyzed after amplification of the DNA using the PCR. Since STR sequences are genetically like VNTR sequences analyzed by RFLP, STR (and D1S80) testing, therefore, combines the analysis of DNA fragment length variations using gel electrophoresis with the advantage of using PCR testing on samples that are unsuitable for RFLP testing. Neither of these technologies, nor the use of STR sequences, is "new or novel" to scientists and are widely used in many areas of research and diagnostics outside of the field of forensic human identification testing.

STR testing is performed on DNA isolated from forensic case samples for a variety of reasons. Some of the common reasons are: (1) to increase the chance of excluding a falsely-accused individual, (2) to aid in determining whether a sample contains a mixture of DNA from more than one individual, (3) to aid in the interpretation of data from a sample containing a mixture of DNA, and (4) to further limit the number of individuals included as a possible donor to the DNA obtained from a sample by providing increased statistical frequencies. Examples of some of the advantages of using STR testing in three cases are presented below. For (1), see case 1 below; for (2) and (3), see case 2 below; and for (4), see case 3 below.

Case 1

Several years ago, a jury in Wisconsin convicted a male of a sexual assault. The information presented to the jury included microscopic examination of pubic hairs found in the victim’s apartment determined to be consistent with the defendant’s hair, an identification of the defendant by the victim viewed through a peephole in her apartment door, and the defendant having no alibi for that time. Cellmark Diagnostics was retained by the defense attorneys handling the appeal. The results of DQa testing (later re-typed using DQA1 strips) on several samples are shown below.

Table 1. DQA1 Results in Post-conviction Case

Sample DQA1 Results
Hair 1 - root 1.1, 4.1
Hair 1 - shaft no results
Hair 2 - root 1.1,2 > 4.1 (with possible 1.2)
Hair 2 - shaft 1.1,2
Victim 1.1,2
Defendant 1.2, 4.1

Based on these results, the defendant is excluded as a source of the DNA obtained from the root of hair 1 if the DNA is from a single source. No additional source of DNA was detected on the shaft. However, if the DNA from the root of hair 1 is from two sources, the defendant cannot be excluded as a source. Hair 2 clearly has DNA from a second source contaminating the root and shaft. The shaft results and the primary results from the root of hair 2 are consistent with the types obtained from the victim, but are not consistent with the types obtained from the defendant. Nonetheless, the defendant could not be excluded as a secondary source of the DNA. The DQa data were presented during testimony at a hearing for a motion for retrial which was denied by the trial court; however, the Court of Appeals ordered a retrial which was affirmed by the Supreme Court of Wisconsin. Faced with a retrial, the defendant’s attorney requested PM and STR testing that had become available during the course of the appeals. The CTT-A results are shown below.

Table 2. CTT-A Results in a Post-conviction Case

Sample CSF1P0 TPOX TH01 XY
Hair 1 - root 10, 11 9,12 6,9 XY
Hair 1 - shaft no results      
Hair 2 - root 10,11 11>9,12

(faint 10)

9,9.3>6 X>Y
Hair 2 - shaft 10,11 11 9,9.3 X
Victim 10,11 11,11 9,9.3 X
Defendant 11,11 10,11 7,9 XY

The results from the root of hair 1 gave no indication of a mixed sample with either CTT-A or PM testing (data not shown) and indicate that the DNA obtained from the root of hair 1 is from a male. The secondary types obtained from the root of hair 2 are consistent with the types from the root of hair 1 suggesting that the two hairs could have come from the same male. The defendant is excluded as the source of the DNA obtained from the root of hair 1 and also is excluded as a source of the DNA obtained from the root and the shaft of hair 2. The results are consistent with the primary types obtained from the "root" of hair 2 being the same DNA that was deposited on the shaft of hair 2 and are consistent with the types obtained from the victim. This illustrates the importance of doing shaft controls when hair roots are tested. In this case, the CTT-A results were crucial for demonstrating that: (1) the hairs could be associated with the victim based on the results on the shaft since the pubic hairs were collected two weeks after the crime and after the victim had moved out of the apartment, and (2) the pubic hairs from a male did not come from the defendant. No testimony of STR and PM results were given in this case.

Based on the reporting of the STR and PM results, the state dropped the charges against the defendant and he was released from prison.

Case 2

In this case, a female was found dead with a towel wrapped around her bloody head and blood was found under her fingernails. A rock with hairs and tissue attached was found nearby, and the suspect, who had been seen with a similar towel earlier, was found to have a scratch on his leg consistent with the position of the rock containing tissue. DQA1, PM and CTT-A testing was performed on these samples and the results are in Tables 3 & 4.

The results of the DQA1, PM and CTT-A tests are consistent with the DNA obtained from the tissue on the rock being from a single male donor; the results are consistent with the types obtained from the suspect. The results from the fingernails and the towel indicate that DNA was obtained from at least two sources, and that one source is female and one source is male. Furthermore, the results from the two mixed samples showed distinct intensity differences for many of the loci. These intensity differences were used [as recommended by The National Research Council Committee on DNA Forensic Science (1)] along with the homozygous results obtained at several of the loci to interpret the data. The victim cannot be excluded as the primary source of the DNA obtained from the fingernails and the towel, and the suspect cannot be excluded as the secondary source of the DNA. With the assumption that there are only two sources of DNA in these two samples, it is possible to determine the types of the primary donor of the DNA as well as determine the types for all of the possible combinations of secondary DNA sources.

There was a challenge to the PCR results since there was no appellate decision for any type of PCR testing in the state and an admissibility hearing was held. Information regarding the RFLP and PCR technologies and their uses in forensic laboratories was presented to the court. The use of PCR and STRs in other fields, the validation work done by Cellmark Diagnostics and by other laboratories, and proficiency testing were also discussed at the pre-trial hearing. The court allowed the STR results to be presented to the jury at trial in a chart format similar to that presented above. Statistical frequencies for the types obtained from the tissue on the rock and statistical frequencies for the possible secondary types obtained from the fingernails and the towel were also presented. Similar statistical calculations for samples containing mixtures of DNA had been presented in an admissibility hearing and to a jury in the case of The State of New Jersey v. Nathaniel Harvey; the PCR results and statistical frequencies were accepted by the state appellate court [151 N.J. 117, 699 A.2d 306 (1997)].

Table 3. DQA1 and PM Results from Case 2

Sample DQA1 LDLR GYPA HBGG D7S8 GC
Fingernails 1.1,1.3* B A B>AC A B>AC
Towel 1.1,1.3* B A B>AC A B>AC
Tissue on rock 1.2 B A AC A AC
Victim 1.1, 1.3 BB AA BB AA BB
Suspect 1.2,1.2 BB AA AC AA AC
* Possible 1.2 type present

 

Table 4. CTT-A Results from Case 2

Sample CSF1P0 TPOX TH01 XY
Fingernails 11,12>10 8,11>10 7>9.3 X>Y
Towel 11,12>10 8,11>10 7>9.3 X>Y
Tissue on rock 10,11 10,11 7,9.3 XY
Victim 11,12 8,11 7,7 XX
Suspect 10,11 10,11 7,9.3 XY

 

Table 5. DQa, PM and CTT STR Results for Case 3.

Sample DQa LDLR GYPA HBGG D7S8 GC CSF1PO TPOX TH01
Car 1.1,4 AB AB AB B AB 11,12 8,11 7,9.3
Victim 1.1,4 AB AB AB BB AB 11,12 8,11 7,9.3
Suspect 1.3,4 BB AA AB AB CC

not done

 

Case 3

A woman died after being run over by an automobile. Various samples from the undercarriage of the suspect’s car were collected and analyzed by PCR testing. The results of the DQa, PM and STR testing are shown in table 5.

In this case, using the data from the DQa and PM tests, the victim cannot be excluded as the source of the DNA obtained from the undercarriage of the car, whereas the suspect is excluded as the source. By adding the CTT STR results to the DQa and PM results, three more opportunities are provided to exclude an individual who is not the true source of the DNA sample and, therefore, the likelihood of individuals in general populations having the same types at all loci as the evidence sample becomes increasingly rare. The frequencies calculated for the DQa and PM results with and without the STR results are shown in table 6. In this case, there is approximately a 100 fold increase in the rareness of the composite genotypes with the addition of the three STR loci.

 

Table 6. Statistical Frequencies for Case 3.

Population database DQa/PM DQa/PM/CTT
Caucasian ~1 in 5500 ~1 in 770,000
African-American ~1 in 11,000 ~1 in 7.5 million

 

The Commonwealth of Massachusetts at that time had appellate rulings regarding RFLP testing but there were no appellate rulings for PCR testing. An admissibility hearing was held in this case in which testimony was given regarding the technologies involved in RFLP and PCR testing, the types of genetic polymorphisms recognized with each test system, and the validation studies conducted for each test system along with other information regarding the validity of human DNA identification testing in forensics and other fields. In addition, testimony was provided regarding PCR databases, review of the databases by independent experts, and the advantages of STR testing such as the existence of a limited number of discrete alleles observed in human populations. The PCR test results were admitted at trial and presented to the jury. This case, along with several other cases, was appealed to the Supreme Judicial Court of Massachusetts. In decisions resulting from two of these cases, the appellate court accepted PCR testing [Commonwealth of Massachusetts v. Vao Sok; 425 Mass. 787, 683 N.E. 2d 671 (1997)] and STR testing [Commonwealth of Massachusetts v. Adam Rosier; 425 Mass. 807, 685 N.E. 2d 739 (1997)]. To our knowledge, this is the first case in the United States where STR testing results have been reviewed by an appellate court.

PRESENTATION OF STR RESULTS IN COURT

Cellmark analysts have been to court in over 30 cases where CTT and/or CTT-A data have been presented to the trier of fact. Testimony was given in admissibility hearings prior to the trial for some of the cases. As in other admissibility hearings for DQA1, PM, D1S80 and RFLP testing, the testimony presented generally included information regarding the wide use of PCR and STR testing in other fields, the genetic bases for the polymorphisms, a description of the technology and types of results, validation studies including relevant publications, training and experience of the scientist and the laboratory, proficiency testing, controls performed, and safeguards in evidence handling and testing to ensure accurate and reliable results. Presentations at trial have ranged from a brief description of the technology and a summary of the data to more extensive testimony including areas routinely covered in admissibility hearings and test results discussed in detail.

The issues raised in cross-examination have generally been similar to those raised previously for other types of PCR testing and for RFLP testing. Such issues include whether STR testing is "new and novel", does multiplexing compromise the assay, is PCR testing so sensitive that contamination may invalidate the results, and are small databases representative of larger populations. Each of these issues can be addressed by the expert witness through publications of validation studies and databases, the use of appropriate laboratory standard operating procedures for evidence handling, testing, and use of controls, through proper training of the laboratory staff and the use of proficiency tests, and through the application of relevant guidelines such as those from TWGDAM (2) and the DNA Advisory Board.

CONCLUSIONS

STR testing results may provide useful information in many types of cases where DNA testing is possible. Since the genetic analysis of STR sequences in DNA has been widely used and accepted by molecular biologists in many areas of study for over 7 years, the use of STRs is not considered to be a new technique to the scientific community. We, as scientists, can be confident taking the results of STR testing into court as long as the data are supported by good laboratory practices. Our role as scientific expert witnesses is: (1) to be prepared with the appropriate validation studies, training, standard operating procedures including the use of appropriate controls, proficiency testing, etc. to support the STR data, (2) to work closely with the attorney or other relevant individuals to determine which cases can benefit from the use of STR testing, and (3) to fairly and accurately present those data in court to the trier of fact.

ACKNOWLEDGMENTS

I would like to acknowledge Anjali Swienton, Melisa Weber and Paula Yates for their diligence and expertise in processing the samples and analyzing the data in the three cases presented; Dr. Robin Cotton for her help and leadership in bringing STR testing into our laboratory and assistance in reviewing data along with Dr. Jennifer Reynolds and Dr. Lisa Forman; and Jodi Kriss and David Sipes for their excellent work on the validation studies on CTT and CTT-A at Cellmark Diagnostics.

REFERENCES

1. The National Research Council on DNA Forensic Science. The Evaluation of Forensic DNA Evidence. 1996; National Academy Press, Washington, D.C.

2. The Technical Working Group of DNA Analysis Methods. Guidelines for a quality assurance program for DNA analysis, Crime Laboratory Digest 1995;22:21-43.

 


Go to proceedings home page